These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10914901)

  • 1. Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects.
    Yoshizumi T; Nozaki S; Fukuchi K; Yamasaki K; Fukuchi T; Maruyama T; Tomiyama Y; Yamashita S; Nishimura T; Matsuzawa Y
    J Nucl Med; 2000 Jul; 41(7):1134-8. PubMed ID: 10914901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency.
    Nozaki S; Tanaka T; Yamashita S; Sohmiya K; Yoshizumi T; Okamoto F; Kitaura Y; Kotake C; Nishida H; Nakata A; Nakagawa T; Matsumoto K; Kameda-Takemura K; Tadokoro S; Kurata Y; Tomiyama Y; Kawamura K; Matsuzawa Y
    Mol Cell Biochem; 1999 Feb; 192(1-2):129-35. PubMed ID: 10331667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Different patterns of 123I-BMIPP myocardial accumulation in patients with type I and II CD36 deficiency].
    Watanabe K; Toba K; Ogawa Y; Aizawa Y; Tanabe N; Miyajima S; Kusano Y; Nagatomo T; Hirokawa Y
    Kaku Igaku; 1997 Dec; 34(12):1125-30. PubMed ID: 9494334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absent myocardial iodine-123-BMIPP uptake and platelet/monocyte CD36 deficiency.
    Hwang EH; Taki J; Yasue S; Fujimoto M; Taniguchi M; Matsunari I; Nakajima K; Shiobara S; Ikeda T; Tonami N
    J Nucl Med; 1998 Oct; 39(10):1681-4. PubMed ID: 9776268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient with type I CD36 deficiency whose myocardium accumulated 123I-BMIPP after 4 years.
    Ito K; Sugihara H; Tanabe T; Zen K; Hikosaka T; Adachi Y; Katoh S; Azuma A; Nakagawa M
    Ann Nucl Med; 2001 Jun; 15(3):271-6. PubMed ID: 11545201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency.
    Watanabe K; Ohta Y; Toba K; Ogawa Y; Hanawa H; Hirokawa Y; Kodama M; Tanabe N; Hirono S; Ohkura Y; Nakamura Y; Kato K; Aizawa Y; Fuse I; Miyajima S; Kusano Y; Nagamoto T; Hasegawa G; Naito M
    Ann Nucl Med; 1998 Oct; 12(5):261-6. PubMed ID: 9839487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [No 123I-BMIPP accumulation in the myocardium and type I CD36 deficiency in a patient with acute subendocardial infarction: a case report].
    Asano Y; Ishii K; Sagiuchi T; Tokita N; Aoki Y; Woodhams R; Katsunuma E; Izumi T; Hayakawa K
    Kaku Igaku; 2002 Feb; 39(1):29-35. PubMed ID: 11915310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial metabolism of 123I-BMIPP in a canine model with ischemia: implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease.
    Hosokawa R; Nohara R; Fujibayashi Y; Okuda K; Ogino M; Hirai T; Fujita M; Tamaki N; Konishi J; Sasayama S
    J Nucl Med; 1999 Mar; 40(3):471-8. PubMed ID: 10086713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency).
    Fukuchi K; Nozaki S; Yoshizumi T; Hasegawa S; Uehara T; Nakagawa T; Kobayashi T; Tomiyama Y; Yamashita S; Matsuzawa Y; Nishimura T
    J Nucl Med; 1999 Feb; 40(2):239-43. PubMed ID: 10025829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of the methyl-branched fatty acid (BMIPP) in animals and humans.
    Kropp J; Eisenhut M; Ambrose KR; Knapp FF; Franke WG
    J Nucl Med; 1999 Sep; 40(9):1484-91. PubMed ID: 10492369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice.
    Coburn CT; Knapp FF; Febbraio M; Beets AL; Silverstein RL; Abumrad NA
    J Biol Chem; 2000 Oct; 275(42):32523-9. PubMed ID: 10913136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP.
    Kurata C; Wakabayashi Y; Shouda S; Mikami T; Takei Y; Tawarahara K; Sugiyama T; Nakano T; Fujisawa S; Andoh A
    J Nucl Med; 1997 Jul; 38(7):1079-84. PubMed ID: 9225794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of myocardial perfusion and fatty acid uptake using a single injection of iodine-123-BMIPP in patients with acute coronary syndromes.
    Kobayashi H; Kusakabe K; Momose M; Okawa T; Inoue S; Iguchi N; Hosoda S
    J Nucl Med; 1998 Jul; 39(7):1117-22. PubMed ID: 9669379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
    Narita M; Kurihara T; Usami M; Honda M
    Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition improves cardiac fatty acid metabolism in patients with congestive heart failure.
    Yamauchi S; Takeishi Y; Minamihaba O; Arimoto T; Hirono O; Takahashi H; Miyamoto T; Nitobe J; Nozaki N; Tachibana H; Watanabe T; Fukui A; Kubota I
    Nucl Med Commun; 2003 Aug; 24(8):901-6. PubMed ID: 12869823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of heart-to-organ ratios of 123I-BMIPP and the dimethyl-substituted 123I-DMIPP fatty acid analogue in humans.
    Sloof GW; Visser FC; van Lingen A; Bax JJ; Eersels J; Teule GJ; Knapp FF
    Nucl Med Commun; 1997 Nov; 18(11):1065-70. PubMed ID: 9423207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of discordant BMIPP and thallium uptake after ischemia and reperfusion in a rat model.
    Higuchi T; Taki J; Nakajima K; Kinuya S; Namura M; Tonami N
    J Nucl Med; 2005 Jan; 46(1):172-5. PubMed ID: 15632049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT.
    Matsunari I; Saga T; Taki J; Akashi Y; Hirai J; Wakasugi T; Aoyama T; Matoba M; Ichiyanagi K; Hisada K
    J Nucl Med; 1994 Aug; 35(8):1279-85. PubMed ID: 8046479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: implications for clinical SPECT.
    Hosokawa R; Nohara R; Fujibayashi Y; Okuda K; Ogino M; Hata T; Fujita M; Tamaki N; Konishi J; Sasayama S
    J Nucl Med; 1997 Dec; 38(12):1857-63. PubMed ID: 9430458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial lipid metabolism in compensated and advanced stages of heart failure: evaluation by canine pacing model with BMIPP.
    Kataoka K; Nohara R; Hosokawa R; Hirai T; Okuda K; Li-Guang C; Fujibayashi Y; Fujita M; Konishi J; Sasayama S
    J Nucl Med; 2001 Jan; 42(1):124-9. PubMed ID: 11197960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.